Intrinsiqq
Anixa Biosciences Inc. logo

Anixa Biosciences Inc. Insider Trading

ANIX

Compare
Cluster buy

4 insiders bought 94K of their own stock in 30 days.

Open-market purchases by executives and directors between Sep 24 and Oct 23. Buying is rarer than selling and says more, but it is one input, not a verdict.

Net open-market
+522K
21 buys · 0 sales
Under a 10b5-1 plan
—
no sales
Insiders who bought / sold
4 / 0
executives and directors
Last open-market buy
Oct 2026
Oct 30, 2026

Get an email when ANIX's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 30
    Amit Kumar
    Chief Executive Officer · bought 5,000 at $3.17
    16K
    0.7% of stake
  • Oct 23
    Lewis H Titterton Jr
    Director · bought 8,000 at $2.98
    24K
    0.8% of stake
  • Oct 22
    Amit Kumar
    Chief Executive Officer · bought 8,000 at $2.72
    22K
    1.2% of stake
  • Sep 30
    Michael Catelani
    President, COO, & CFO · bought 5,500 at $2.84
    16K
    12% of stake
  • Sep 24
    Amit Kumar
    Chief Executive Officer · bought 7,000 at $2.78
    19K
    1.1% of stake
  • Sep 24
    Arnold M Baskies
    Director · bought 5,000 at $2.76
    14K
    3.7% of stake
  • Sep 23
    Lewis H Titterton Jr
    Director · bought 49,036 at $2.69
    132K
    4.9% of stake
  • Sep 10
    Amit Kumar
    Chief Executive Officer · bought 3,000 at $2.75
    8K
    0.5% of stake
  • Sep 10
    Lewis H Titterton Jr
    Director · bought 10,000 at $2.73
    27K
    1.0% of stake
  • Sep 10
    Amit Kumar
    Chief Executive Officer · bought 5,000 at $2.76
    14K
    0.8% of stake
  • Jul 31
    Amit Kumar
    Chief Executive Officer · bought 5,000 at $3.47
    17K
    0.8% of stake
  • Jul 27
    Amit Kumar
    Chief Executive Officer · bought 5,000 at $3.44
    17K
    0.8% of stake
  • Jul 27
    Amit Kumar
    Chief Executive Officer · bought 3,188 at $3.37
    11K
    0.5% of stake
  • Jul 24
    Amit Kumar
    Chief Executive Officer · bought 3,000 at $3.73
    11K
    0.5% of stake
  • Jul 20
    Amit Kumar
    Chief Executive Officer · bought 5,000 at $3.46
    17K
    0.8% of stake
  • Jul 20
    Lewis H Titterton Jr
    Director · bought 12,000 at $3.47
    42K
    1.2% of stake
  • Jul 15
    Lewis H Titterton Jr
    Director · bought 2,797 at $3.28
    9K
    0.3% of stake
  • Jul 10
    Amit Kumar
    Chief Executive Officer · bought 5,000 at $3.04
    15K
    0.8% of stake
  • Jun 16
    Lewis H Titterton Jr
    Director · bought 2,836 at $2.64
    7K
    0.3% of stake
  • Jun 12
    Amit Kumar
    Chief Executive Officer · bought 21,000 at $2.50
    53K
    3.4% of stake
  • Jan 28
    Arnold M Baskies
    Director · bought 10,000 at $3.04
    30K
    8.0% of stake
  • Jul 31, 2025
    Lewis H Titterton Jr
    Director · bought 10,000 at $3.08
    31K
    1.1% of stake
  • Jul 30, 2025
    Amit Kumar
    Chief Executive Officer · bought 5,000 at $3.16
    16K
    0.9% of stake
  • Jul 18, 2025
    Arnold M Baskies
    Director · bought 5,000 at $3.39
    17K
    4.2% of stake
  • Jul 11, 2025
    Lewis H Titterton Jr
    Director · bought 10,000 at $3.14
    31K
    1.1% of stake
  • Jul 11, 2025
    Amit Kumar
    Chief Executive Officer · bought 5,000 at $3.15
    16K
    0.9% of stake
  • Jun 4, 2025
    Amit Kumar
    Chief Executive Officer · bought 10,000 at $2.85
    29K
    1.8% of stake
  • Jan 28, 2025
    Arnold M Baskies
    Director · bought 5,000 at $2.82
    14K
    4.3% of stake
  • Jan 23, 2025 – Jan 24, 2025
    Lewis H Titterton Jr
    Director · bought 3,000 at avg $2.94
    9K
    0.3% of stake
  • Jan 22, 2025
    Lewis H Titterton Jr
    Director · bought 2,000 at $3.01
    6K
    0.2% of stake
  • Jan 21, 2025
    Lewis H Titterton Jr
    Director · bought 6,000 at $2.59
    16K
    0.7% of stake
  • Jan 17, 2025
    Lewis H Titterton Jr
    Director · bought 10,000 at $2.57
    26K
    1.1% of stake
  • Jan 15, 2025
    Amit Kumar
    Chief Executive Officer · bought 43,000 at $2.23
    96K
    8.3% of stake
  • Jan 15, 2025
    Michael Catelani
    President, COO, & CFO · bought 9,289 at $2.15
    20K
    26% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ANIX, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with ANIX

CompareIntrinsic value
LIPOLipella Pharmaceuticals Inc.
$0.00+0.00%25
CARMCarisma Therapeutics Inc.
$0.00+0.00%60
SLNOSoleno Therapeutics Inc
No recent price25
OPKOpko Health Inc.
$1.57-2.48%28
IBIOiBio, Inc.
$0.80+0.01%10
LFVNLifeVantage Corporation
$4.15-15.13%68
PAHCPhibro Animal Health Corporation
$33.29-2.32%57

Held by ETFs

ANIX is in 1 US ETF. The largest of them, with ANIX's weight in each:

Spot a number that looks wrong? Check it in ANIX's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing ANIX

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.